Internal link ProQR Completes Enrollment of its Pivotal Trial of Sepofarsen for the Treatment of LCA10 January 07, 2021 at 12:00 PM UTC
Internal link ProQR Therapeutics Announces Results for the Third Quarter of 2014 November 24, 2014 at 12:00 PM UTC
Internal link ProQR Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares September 23, 2014 at 05:37 PM UTC